Photo: Getty Images
Awesome, great news! Eli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drug maker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit. Tap here for full article. Follow us @hookeranddb